A share price of Incyte Corp [INCY] is currently trading at $105.98, up 0.74%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INCY shares have gain 13.37% over the last week, with a monthly amount glided 25.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on November 03, 2025, when Guggenheim upgraded its rating to a Buy but kept the price target unchanged to $125 for it. Previously, Oppenheimer downgraded its rating to Perform on October 08, 2025. On August 06, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $89 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $90 on August 01, 2025. Stifel upgraded its rating to a Buy but $107 remained the price target by the analyst firm on June 16, 2025. William Blair downgraded its rating to Mkt Perform for this stock on March 18, 2025. In a note dated March 18, 2025, Guggenheim downgraded an Neutral rating on this stock.
Incyte Corp experienced fluctuations in its stock price throughout the past year between $53.56 and $106.47. Currently, Wall Street analysts expect the stock to reach $90.83 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $105.98 at the most recent close of the market. An investor can expect a potential drop of -14.3% based on the average INCY price forecast.
Analyzing the INCY fundamentals
Trailing Twelve Months sales for Incyte Corp [NASDAQ:INCY] were 4.81B which represents 20.05% growth. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.19, Equity is 0.3 and Total Capital is 0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 104.39 points at the first support level, and at 102.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 106.98, and for the 2nd resistance point, it is at 107.99.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Incyte Corp [NASDAQ:INCY] is 3.20. Further, the Quick Ratio stands at 3.13, while the Cash Ratio is 1.83. Considering the valuation of this stock, the price to sales ratio is 4.32, the price to book ratio is 4.47 and price to earnings (TTM) ratio is 17.78.
Transactions by insiders
Recent insider trading involved Stein Steven H, EVP & Chief Medical Officer, that happened on Nov 05 ’25 when 5233.0 shares were sold. EVP & General Counsel, Denton Sheila A. completed a deal on Nov 04 ’25 to sell 598.0 shares. Meanwhile, Officer STEVEN STEIN bought 5233.0 shares on Nov 05 ’25.
